Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2-Reference-Cited by-同舟云学术

Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2

Published:2011-01-12 Issue:3 Volume:162 Page:688-700
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Pan Zhenwei,Zhao Weiming,Zhang Xiangying,Wang Bing,Wang Jinghao,Sun Xuelin,Liu Xuantong,Feng Shuya,Yang Baofeng,Lu Yanjie

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.2010.01070.x/fullpdf

Reference43 articles.

1. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components;Boluyt;Circ Res,1994

2. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling;Bujak;Cardiovasc Res,2007

3. Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation;Chan;Anticancer Res,2009

4. Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone;Chen;Am J Physiol Heart Circ Physiol,2006

5. Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction;van Deel;Free Radic Biol Med,2008

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flavonoids: Potential therapeutic agents for cardiovascular disease;Heliyon;2024-06

2. The Senescent Heart—“Age Doth Wither Its Infinite Variety”;International Journal of Molecular Sciences;2024-03-22

3. An antihypertensive drug-AT1 inhibitor attenuated BRCA development promoted by chronic psychological stress via Ang II/PARP1/FN1 pathway;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03

4. Breviscapine protects against pathological cardiac hypertrophy by targeting FOXO3a-mitofusin-1 mediated mitochondrial fusion;Free Radical Biology and Medicine;2024-02

5. Effects of scutellarin on the mechanism of cardiovascular diseases: a review;Frontiers in Pharmacology;2024-01-08